Merck
HomeWebinarsOvercome Cell Therapy Manufacturing Challenges with Novel Acoustic Technology Platform

Overcome Cell Therapy Manufacturing Challenges with Novel Acoustic Technology Platform



WEBINAR

Acoustic cell processing is a novel and disruptive technology that allows for the manipulation of cells via sound waves and can be employed for a variety of processing steps including cell selection and wash and concentrate applications. This touchless cell processing technique is employed in ekko™ Select and ekko™ System to overcome common industry challenges observed with traditional mechanical technologies, to deliver high-quality cells. Our platform was developed for cell therapy organizations focused on research programs through manufacturing. And was designed for organizations in need of an industrialized cell processing system uniquely capable of gentle, scalable, reproducible, and adaptable processing required to achieve the promise of advanced therapies.

In this webinar, you will:

  • Learn how we apply the principles of acoustics for use across multiple cell therapy manufacturing unit operations
  • Explore unmatched flexibility and ease-of-use with our ekko™ System for wash and concentrate applications
  • Discover the latest tool in development for T cell selection with ekko™ Select, the system designed to deliver high recovery and purity in reduced time

Speakers

Kimberly Stewart, Ph.D.

Kimberly Stewart, Ph.D.

Merck

Scientist III

Kimberly D. Stewart is an R&D scientist with broad experience in protein and nucleic acid chemistries. In her current role, Kimberly leverages her expertise in molecular recognition applications to support the development of a cell therapy manufacturing platform. As an early-career scientist, Kimberly maintains an imaginative approach to complex queries, working to introduce novel process solutions where necessary. Kimberly holds a Ph.D. in analytical chemistry and has a unique composite of knowledge in chemical biology, analytical instrumentation, and molecular-level assay development.

Jack Saloio

Jack Saloio

Merck

R&D Engineer III

Jack Saloio is an R&D engineer who has been developing acoustic technologies for biopharmaceutical and cell therapy manufacturing for more than six years. In his role at Merck, he has led design selection, process optimization, and automation efforts within the ekko™ Select project. His experience with this novel technology continues to play an important role as the project progresses. Jack holds a B.S. in mechanical engineering from Western New England University.